Congress Asset Management CO Penumbra Inc Transaction History

Congress Asset Management CO

  • $14 Billion
  • Q4 2025

A detailed history of Congress Asset Management CO transactions in Penumbra Inc stock. As of the latest transaction made, Congress Asset Management CO holds 382,350 shares of PEN stock, worth $106 Million. This represents 0.76% of its overall portfolio holdings.

Number of Shares
382,350
Previous 429,172 10.91%
Holding current value
$106 Million
Previous $109 Million 2.05%
% of portfolio
0.76%
Previous 0.76%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 09, 2026
SELL
$225.54 - $280.29 $10.6 Million - $13.1 Million
-46,822 Reduced 10.91%
382,350 $106 Million
Q3 2025

Oct 10, 2025
SELL
$227.15 - $287.09 $5.8 Million - $7.33 Million
-25,527 Reduced 5.61%
429,172 $109 Million
Q2 2025

Jul 16, 2025
SELL
$253.22 - $299.78 $23.2 Million - $27.5 Million
-91,582 Reduced 16.76%
454,699 $117 Million
Q1 2025

Apr 11, 2025
SELL
$237.28 - $303.76 $14.9 Million - $19 Million
-62,681 Reduced 10.29%
546,281 $146 Million
Q4 2024

Jan 30, 2025
SELL
$190.97 - $253.66 $5.46 Million - $7.25 Million
-28,592 Reduced 4.48%
608,962 $145 Million
Q3 2024

Oct 28, 2024
SELL
$163.64 - $210.12 $1.04 Million - $1.34 Million
-6,377 Reduced 0.99%
637,554 $124 Million
Q2 2024

Aug 02, 2024
BUY
$172.27 - $223.95 $106 Million - $138 Million
617,355 Added 2322.98%
643,931 $116 Million
Q1 2024

Apr 11, 2024
BUY
$220.09 - $273.15 $4.62 Million - $5.73 Million
20,981 Added 375.0%
26,576 $5.93 Million
Q4 2023

Mar 04, 2024
SELL
$181.44 - $260.22 $35,562 - $51,003
-196 Reduced 3.38%
5,595 $1.41 Million
Q3 2023

Nov 01, 2023
SELL
$240.69 - $338.77 $352,851 - $496,636
-1,466 Reduced 20.2%
5,791 $1.4 Million
Q2 2023

Jul 27, 2023
SELL
$271.54 - $344.06 $302,767 - $383,626
-1,115 Reduced 13.32%
7,257 $2.5 Million
Q1 2023

Apr 21, 2023
SELL
$220.43 - $278.69 $232,112 - $293,460
-1,053 Reduced 11.17%
8,372 $2.33 Million
Q4 2022

Jan 18, 2023
SELL
$151.88 - $228.5 $309,379 - $465,454
-2,037 Reduced 17.77%
9,425 $0
Q3 2022

Nov 08, 2022
SELL
$120.36 - $205.88 $2.66 Million - $4.55 Million
-22,123 Reduced 65.87%
11,462 $2.17 Million
Q2 2022

Aug 02, 2022
BUY
$116.09 - $227.33 $72,788 - $142,535
627 Added 1.9%
33,585 $4.18 Million
Q1 2022

Apr 20, 2022
SELL
$187.51 - $283.98 $16,500 - $24,990
-88 Reduced 0.27%
32,958 $7.32 Million
Q4 2021

Jan 28, 2022
SELL
$238.08 - $288.0 $201,653 - $243,936
-847 Reduced 2.5%
33,046 $9.5 Million
Q3 2021

Nov 08, 2021
BUY
$250.72 - $291.24 $185,783 - $215,808
741 Added 2.24%
33,893 $9.03 Million
Q2 2021

Aug 05, 2021
SELL
$235.0 - $310.7 $65,095 - $86,063
-277 Reduced 0.83%
33,152 $9.09 Million
Q1 2021

May 05, 2021
SELL
$175.6 - $291.43 $28,447 - $47,211
-162 Reduced 0.48%
33,429 $9.05 Million
Q4 2020

Jan 26, 2021
SELL
$174.98 - $272.83 $344,360 - $536,929
-1,968 Reduced 5.53%
33,591 $5.88 Million
Q3 2020

Nov 03, 2020
SELL
$185.27 - $238.73 $191,013 - $246,130
-1,031 Reduced 2.82%
35,559 $6.91 Million
Q2 2020

Jul 23, 2020
SELL
$153.32 - $191.72 $51,055 - $63,842
-333 Reduced 0.9%
36,590 $6.54 Million
Q1 2020

Apr 21, 2020
SELL
$124.34 - $193.76 $230,277 - $358,843
-1,852 Reduced 4.78%
36,923 $5.96 Million
Q4 2019

Feb 10, 2020
SELL
$134.81 - $177.8 $150,043 - $197,891
-1,113 Reduced 2.79%
38,775 $6.37 Million
Q3 2019

Nov 01, 2019
SELL
$131.82 - $183.4 $183,493 - $255,292
-1,392 Reduced 3.37%
39,888 $5.37 Million
Q2 2019

Aug 07, 2019
SELL
$124.65 - $167.39 $96,229 - $129,225
-772 Reduced 1.84%
41,280 $6.61 Million
Q1 2019

May 08, 2019
BUY
$115.84 - $160.31 $237,703 - $328,956
2,052 Added 5.13%
42,052 $6.18 Million
Q4 2018

Jan 25, 2019
BUY
$113.42 - $156.48 $4.54 Million - $6.26 Million
40,000 New
40,000 $4.89 Million

Others Institutions Holding PEN

# of Institutions
474
Shares Held
30.6M
Call Options Held
309K
Put Options Held
95.9K
View Full List

About Penumbra Inc

PEN Quotes by TradingView
  • Ticker PEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,888,400
  • Market Cap $10.6B
  • Description
  • Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...
More about PEN
Track This Portfolio

Track Congress Asset Management CO Portfolio

Follow Congress Asset Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Congress Asset Management CO , based on Form 13F filings with the SEC.

News

Stay updated on Congress Asset Management CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email